pemafibrate
kowa pharmaceuticals
['prominent']
the triglyceride (tg) story got more interesting at #aha22 on saturday! prominent trial: big in tg doesn't reduce cv events. fibrates seem to be very near over really nice work below by sam sherratt, , colleagues. more support for epa? 
@hopkinsheart cardiology fellow, previously @OslerResidency. Podcast producer @cardionerds. Social Media Editor @JACCJournals. Views my own